Strikingly, the authors observed a strong delay in leukemia onset and a reduced tumor penetrance in the SCLm13tgLMO1tg versus SCLtgLMO1tg transgenic mice, suggesting that E protein inhibition is not the main oncogenic property of SCL in this model of murine T cell leukemogenesis. The gene discussed is TAL1; the disease is leukemia.